Bioventus Inc.
BVS | NASDAQ
$13.60
+$0.29 (+2.18%)
Sep 22, 2026, 12:42 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 21.88 | -20.19 | -2.12 | -1.01 | -96.60 | 43.66 |
PEG Ratio | -0.13 | 0.26 | 0.55 | 0 | 0.72 | 0.16 |
PS Ratio | 0.87 | 1.20 | 0.64 | 0.31 | 1.53 | 2.25 |
PB Ratio | 2.69 | 4.64 | 1.90 | 0.49 | 1.44 | 5.09 |
P/FCF Ratio | 6.94 | 18.16 | 41.36 | -10.67 | 313.61 | 14.16 |
P/OCF Ratio | 6.70 | 17.69 | 21.52 | -11.84 | 28.66 | 10.09 |
OCF/S Ratio | 13.02 | 6.77 | 2.99 | -2.64 | 5.34 | 22.36 |
Debt / Equity Ratio | 1.69 | 2.27 | 2.27 | 1.29 | 0.78 | 1.32 |
Quick Ratio | 1.19 | 0.87 | 1.01 | 0.62 | 1.11 | 1.49 |
Current Ratio | 1.70 | 1.31 | 1.53 | 0.90 | 1.45 | 1.73 |
Asset Turnover | 0.83 | 0.79 | 0.63 | 0.37 | 0.35 | 0.65 |
Interest Coverage | 2.21 | -0.31 | -2.01 | -13.91 | 10.85 | 2.18 |
Return on Equity | 12.35% | -22.67% | -90% | -48.80% | 4.22% | 11.54% |
Return on Assets | 3.33% | -4.61% | -19.27% | -11.56% | 1.58% | 3.32% |
Return on Invested Capital | 10.79% | -1.96% | -12.32% | -11.62% | 1.13% | 5.08% |
Dividend Yield | n/a | n/a | n/a | n/a | 0.06% | 2.75% |
Payout Ratio | n/a | n/a | n/a | n/a | 1.89% | 121.17% |
FCF Payout Ratio | n/a | n/a | n/a | n/a | -2.07% | 48.47% |
Gross Profit Margin | 67.32% | 67.72% | 64.06% | 64.65% | 70.25% | 72.71% |
Net Profit Margin | 4% | -5.85% | -30.49% | -30.99% | 4.50% | 5.11% |
Pretax Profit Margin | 4.53% | -8.57% | -23.64% | -36.91% | 2.20% | 4.96% |
Operating Profit Margin | 10.31% | -2.09% | -15.95% | -32.66% | 2.80% | 6.61% |
FCF Margin | 12.57% | 6.59% | 1.56% | -2.93% | 0.49% | 15.92% |
EBITDA Margin | 17.46% | 6.84% | -4.50% | -23.75% | 10.55% | 16.91% |
Add to Watchlist
Select watchlists to add or remove BVS